-
1
-
-
0000464842
-
Pelvic tumors other than fibromas of the ovary with ascites and hydrothorax
-
13154792 1:STN:280:DyaG2c%2FnsVOntA%3D%3D
-
JV Meigs 1954 Pelvic tumors other than fibromas of the ovary with ascites and hydrothorax Obstet Gynecol 3 471 486 13154792 1:STN:280: DyaG2c%2FnsVOntA%3D%3D
-
(1954)
Obstet Gynecol
, vol.3
, pp. 471-486
-
-
Meigs, J.V.1
-
2
-
-
0029048806
-
Pseudo-Meigs' syndrome and lupus
-
7649329 10.1016/0020-7292(95)02355-G 1:STN:280:DyaK2MznslCrtw%3D%3D
-
EA Widra J Armstrong 1995 Pseudo-Meigs' syndrome and lupus Int J Gynaecol Obstet 49 2 193 194 7649329 10.1016/0020-7292(95)02355-G 1:STN:280: DyaK2MznslCrtw%3D%3D
-
(1995)
Int J Gynaecol Obstet
, vol.49
, Issue.2
, pp. 193-194
-
-
Widra, E.A.1
Armstrong, J.2
-
3
-
-
15544378399
-
Ascites, pleural effusion, and CA 125 elevation in an SLE patient, either a Tjalma syndrome or, due to the migrated Filshie clips, a pseudo-Meigs syndrome
-
DOI 10.1016/j.ygyno.2004.12.022
-
WA Tjalma 2005 Ascites, pleural effusion, and CA 125 elevation in an SLE patient, either a Tjalma syndrome or, due to the migrated Filshie clips, a pseudo-Meigs syndrome Gynecol Oncol 97 1 288 291 15790480 10.1016/j.ygyno.2004. 12.022 (Pubitemid 40403716)
-
(2005)
Gynecologic Oncology
, vol.97
, Issue.1
, pp. 288-291
-
-
Tjalma, W.A.A.1
-
4
-
-
32644468938
-
Tjalma's syndrome [10]
-
DOI 10.1016/S0140-6736(06)68220-2, PII S0140673606682202
-
WA Tjalma 2006 Tjalma's syndrome Lancet 367 9510 567 568 16488797 10.1016/S0140-6736(06)68220-2 (Pubitemid 43247567)
-
(2006)
Lancet
, vol.367
, Issue.9510
, pp. 567-568
-
-
Tjalma, W.A.A.1
-
5
-
-
27644589137
-
Pseudo-pseudo Meigs' syndrome
-
DOI 10.1016/S0140-6736(05)67666-0, PII S0140673605676660
-
R Schmitt W Weichert W Schneider FC Luft R Kettritz 2005 Pseudo-pseudo Meigs' syndrome Lancet 366 9497 1672 16271650 10.1016/S0140-6736(05)67666-0 (Pubitemid 41552424)
-
(2005)
Lancet
, vol.366
, Issue.9497
, pp. 1672
-
-
Schmitt, R.1
Weichert, W.2
Schneider, W.3
Luft, F.C.4
Kettritz, R.5
-
7
-
-
0033781432
-
Meigs syndrome and bfalse positiveQ preoperative serum CA-125 levels: Analysis of ten cases
-
11055482 1:STN:280:DC%2BD3crgsVyjsw%3D%3D
-
B Patsner 2000 Meigs syndrome and bfalse positiveQ preoperative serum CA-125 levels: analysis of ten cases Eur J Gynaecol Oncol 21 362 363 11055482 1:STN:280:DC%2BD3crgsVyjsw%3D%3D
-
(2000)
Eur J Gynaecol Oncol
, vol.21
, pp. 362-363
-
-
Patsner, B.1
-
8
-
-
0036224253
-
The role of inflammatory cytokines in Meigs' syndrome
-
DOI 10.1016/S0029-7844(01)01602-7, PII S0029784401016027
-
Y Abramov SO Anteby SJ Fasouliotis V Barak 2002 The role of inflammatory cytokines in Meigs' syndrome Obstet Gynecol 99 917 919 11975958 10.1016/S0029-7844(01)01602-7 1:CAS:528:DC%2BD38XjtVSjsLc%3D (Pubitemid 34442419)
-
(2002)
Obstetrics and Gynecology
, vol.99
, Issue.5 SUPPL. 1
, pp. 917-919
-
-
Abramov, Y.1
Anteby, S.O.2
Fasouliotis, S.J.3
Barak, V.4
-
9
-
-
0036314278
-
Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus
-
DOI 10.1191/0961203302lu199oa
-
E Robak A Wozniacka A Sysa-Jedrejowska H Stepien T Robak 2002 Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus Lupus 11 6 348 355 12139372 10.1191/0961203302lu199oa 1:CAS:528:DC%2BD38XlvFyrt7g%3D (Pubitemid 34760632)
-
(2002)
Lupus
, vol.11
, Issue.6
, pp. 348-355
-
-
Robak, E.1
Wozniacka, A.2
Sysa-Jedrzejowska, A.3
Stepien, H.4
Robak, T.5
-
10
-
-
0031865023
-
Mechanism of action of leflunomide in rheumatoid arthritis
-
RI Fox 1998 Mechanism of action of leflunomide in rheumatoid arthritis J Rheumatol Suppl 53 20 26 9666414 1:CAS:528:DyaK1cXks1Kjuro%3D (Pubitemid 28335318)
-
(1998)
Journal of Rheumatology
, vol.25
, Issue.SUPPL. 53
, pp. 20-26
-
-
Fox, R.I.1
-
11
-
-
0034925128
-
Benefits of leflunomide in systemic lupus erythematosus: A pilot observational study
-
DOI 10.1191/096120301678416033
-
CF Remer MH Weisman DJ Wallace 2001 Benefits of leflunomide in systemic lupus erythematosus: a pilot observational study Lupus 10 480 483 11480845 10.1191/096120301678416033 1:CAS:528:DC%2BD3MXlvVKis78%3D (Pubitemid 32675047)
-
(2001)
Lupus
, vol.10
, Issue.7
, pp. 480-483
-
-
Remer, C.F.1
Weisman, M.H.2
Wallace, D.J.3
-
12
-
-
33144490424
-
Safety and efficacy of leflunomide in the treatment of lupus nephritis refractory or intolerant to traditional immunosuppressive therapy: An open label trial [7]
-
DOI 10.1136/ard.2005.044248
-
LS Tam EK Li CK Wong CW Lam WC Li CC Szeto 2006 Safety and efficacy of leflunomide in the treatment of lupus nephritis refractory or intolerant to traditional immunosuppressive therapy: an open label trial Ann Rheum Dis 65 3 417 418 16474039 10.1136/ard.2005.044248 (Pubitemid 43268242)
-
(2006)
Annals of the Rheumatic Diseases
, vol.65
, Issue.3
, pp. 417-418
-
-
Tam, L.-S.1
Li, E.K.2
Wong, C.-K.3
Lam, C.W.K.4
Li, W.-C.5
Szeto, C.-C.6
-
15
-
-
67651230875
-
Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis
-
19605743 10.1136/ard.2008.099093 1:CAS:528:DC%2BD1MXhtFGqsrjP
-
PB Grabar B Rozman D Logar S Praprotnik V Dolzan 2009 Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis Ann Rheum Dis 68 8 1367 1368 19605743 10.1136/ard.2008.099093 1:CAS:528:DC%2BD1MXhtFGqsrjP
-
(2009)
Ann Rheum Dis
, vol.68
, Issue.8
, pp. 1367-1368
-
-
Grabar, P.B.1
Rozman, B.2
Logar, D.3
Praprotnik, S.4
Dolzan, V.5
|